000			05665nam a22003975i 4500
999			_c395023 _d395023
001			395023
003			ES-MaUEC
005			20230311153311.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			230311s2022 si | s |||| 0|eng d
020			_a9789811948008
024	7		_a10.1007/978-981-19-4800-8 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC600 _b2022 EB
245	0	0	_aRole of Microorganisms in Pathogenesis and Management of Autoimmune Diseases : _bVolume II: Kidney, Central Nervous System, Eye, Blood, Blood Vessels & Bowel _cedited by Mitesh Kumar Dwivedi, A. Sankaranarayanan, E. Helen Kemp, Yehuda Shoenfeld
250			_a1st edition 2022
264		1	_aSingapore _bSpringer International Publishing _c2022
300			_a1 recurso en línea (XXI, 542 páginas) _b1 ilustraciones
336			_atexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_aarchivo de texto _bPDF
505	0		_aPART I: HUMAN MICROBIOME, VACCINES AND AUTOIMMUNITY -- Chapter 1. Autoimmunity and Microbiome -- Chapter 2. The vaccines induced autoimmunity -- Chapter 3. COVID-19 and Autoimmunity -- Chapter 4. The protective discourse between infections and autoimmunity -- PART II: MICROORGANISMS IN PATHOGENESIS & MANAGEMENT OF AUTOIMMUNE KIDNEY DISEASES & ADRENAL INSUFFICIENCY -- Chapter 5. Microorganisms in pathogenesis and management of Anti-Neutrophil Cytoplasmic Antibody- (ANCA)- Associated Vasculitis -- Chapter 6. Microorganisms in pathogenesis and management of IgA Vasculitis and IgA Nephropathy -- Chapter 7. Microorganisms in pathogenesis and management of immune mediated glomerulopathies -- Chapter 8. Microorganisms in pathogenesis and management of Autoimmune Addison's Disease (ADD) -- PART III: MICROORGANISMS IN PATHOGENESIS & MANAGEMENT OF CENTRAL NERVOUS SYSTEM (CNS) DEMYELINATING AUTOIMMUNE DISEASES -- Chapter 9. Microorganisms in pathogenesis and management of Multiple Sclerosis (MS) -- Chapter 10. Microorganisms in pathogenesis and management of Guillain-Barre syndrome (GBS) -- Chapter 11. Microorganisms in pathogenesis and management of Neuromyelitis Optica -- Chapter 12. Microorganisms in pathogenesis and management of Acute Disseminated Encephalomyelitis (ADEM) -- PART IV: MICROORGANISMS IN PATHOGENESIS & MANAGEMENT OF INFLAMMATORY BOWEL DISEASES (IBDs) -- Chapter 13. Microorganisms in pathogenesis and management of Ulcerative colitis (UC) -- Chapter 14. Microorganisms in pathogenesis and management of Crohn's disease (CD) -- Chapter 15. Microorganisms in pathogenesis and management of Pouchitis -- Chapter 16. Microorganisms in pathogenesis and management of Coeliac Disease -- PART V: MICROORGANISMS IN PATHOGENESIS & MANAGEMENT OF AUTOIMMUNE BLOOD & BLOOD VESSEL DISORDERS -- Chapter 17. Microorganisms in pathogenesis and management of Anti-Phospholipid Syndrome (Hughes syndrome) -- Chapter 18. Microorganisms in pathogenesis and management of Behçet Disease (BD) -- Chapter 19. Microorganisms in pathogenesis and management of Immune Thrombocytopenia -- PART VI: MICROORGANISMS IN PATHOGENESIS & MANAGEMENT OF AUTOIMMUNE EYE DISEASES -- Chapter 20. Microorganisms in pathogenesis and management of Autoimmune Uveitis -- Chapter 21. Microorganisms in pathogenesis and management of Autoimmune Retinopathy (AIR) -- Chapter 22. Microorganisms in pathogenesis and management of Type 1 Diabetes (T1D) -- Chapter 23. The influence of the microbiome and genetic associations on immune functions and on autoimmune and autoinflammatory diseases -- Chapter 24. Current challenges in research with exploring the microbial pathomechanisms of Autoimmune diseases -- Chapter 25. Future therapeutic prospects in dealing with autoimmune diseases: Treatment Based on the Microbiome Model.
520			_aThis book, which is the second volume of Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases, provides comprehensive coverage on how microbial pathogens can subvert our immune system into responding against self and resulting in autoimmune diseases. In particular, the book covers the different aspects of linking gut microbiota dysbiosis with autoimmune mechanisms involved in disease development to identify future effective approaches based on the gut microbiota for preventing these autoimmune diseases. Contributions in the book focus on the role of microbiota/probiotics and their distinct mechanisms exerted in the management of autoimmune diseases of the kidney, central nervous system, eye, blood vessel, and bowel. This could help in better understanding to design of therapeutic strategies that can be deployed to prevent these autoimmune diseases. The book has an interdisciplinary appeal and scholars with an interest in immunology, medical microbiology, and nutritional sciences will value its contribution. Overall, the book gives new dimension and insight into the aspects of microbial role in autoimmune disease pathogenesis.
988			_aSpringer_BiomedLife_2022
650		7	_2embne _9143353 _aEnfermedades autoinmunes _xEtiología médica
776	0	8	_iPrinted edition: _z9789811947995
776	0	8	_iPrinted edition: _z9789811948015
776	0	8	_iPrinted edition: _z9789811948022
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-19-4800-8 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b03/2023 _dz _eIG _zSI